(Q46411630)

English

Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

hypocholesterolemia

0 references

author name string

Conde K

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

Pineda G

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

Newton RS

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

Fernandez ML

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

58

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

1209-1219

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Separation of plasma lipoproteins by density-gradient ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Regulation of apolipoprotein B-containing lipoproteins by dietary soluble fiber in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Assay of cholesteryl ester transfer activity and purification of a cholesteryl ester transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Methods to determine oxidation of low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Carbohydrate-fat exchange and regulation of hepatic cholesterol and plasma lipoprotein metabolism in the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Hepatic acyl-CoA:cholesterol acyltransferase. Development of a standard assay and determination in patients with cholesterol gallstones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

The theory of tracer experiments with 131I-labelled plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Effects of simvastatin on apoB metabolism and LDL subfraction distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Simvastatin decreases the hepatic secretion of very‐low‐density lipoprotein apolipoprotein B‐100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Oxidized LDL binding to a macrophage-secreted extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(99)00203-8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/10484079

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46411630&oldid=2129134777"